Literature DB >> 15764875

FDG-PET imaging in primary bilateral adrenal lymphoma: a case report and review of the literature.

Rakesh Kumar1, Yan Xiu, Ayse Mavi, Ghassan El-Haddad, Hongming Zhuang, Abass Alavi.   

Abstract

Primary adrenal lymphoma is an extremely rare entity. Only 70 cases have been reported in the English literature. Most of the patients are elderly men with bilateral adrenal masses without extraadrenal involvement. The most common presenting symptoms are fever, weight loss, lumbar pain, and/or symptoms of adrenal insufficiency. Of the cases reported, CT, ultrasound, and MRI were the imaging modalities used to describe the lesions. FDG PET has been used successfully to differentiate benign and malignant adrenal masses. The authors report a 67-year-old man diagnosed as having primary bilateral adrenal lymphoma and having no evidence of extraadrenal spread who was evaluated from the time of diagnosis to complete remission with FDG PET scanning. The literature of this unusual neoplasm is reviewed in detail.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15764875     DOI: 10.1097/01.rlu.0000155983.46815.1c

Source DB:  PubMed          Journal:  Clin Nucl Med        ISSN: 0363-9762            Impact factor:   7.794


  24 in total

Review 1.  Metabolic positron emission tomography imaging in cancer detection and therapy response.

Authors:  Aizhi Zhu; Daniel Lee; Hyunsuk Shim
Journal:  Semin Oncol       Date:  2011-02       Impact factor: 4.929

Review 2.  [Extranodal abdominal lymphomas].

Authors:  T F Weber; S Dietrich; J Nattenmüller
Journal:  Radiologe       Date:  2018-01       Impact factor: 0.635

Review 3.  Metabolic and anatomic characteristics of benign and malignant adrenal masses on positron emission tomography/computed tomography: a review of literature.

Authors:  Asha Kandathil; Ka Kit Wong; Daniel J Wale; Maria Chiara Zatelli; Anna Margherita Maffione; Milton D Gross; Domenico Rubello
Journal:  Endocrine       Date:  2014-10-02       Impact factor: 3.633

4.  Primary Non Hodgkin's Lymphoma of Left Adrenal Gland - A Rare Presentation.

Authors:  Anil Khurana; Paramjeet Kaur; Ashok K Chauhan; Sant Parkash Kataria; Nupur Bansal
Journal:  J Clin Diagn Res       Date:  2015-04-01

5.  Primary adrenal tuberculosis infection in patients with Behcet's disease presenting as isolated adrenal metastasis by 18F-FDG PET/CT: a rare case report and literature review.

Authors:  Qiliang Teng; Bo Fan; Yutong Wang; Shuang Wen; Honglong Wang; Tianqing Liu; Liang Wang
Journal:  Gland Surg       Date:  2021-12

6.  Bilateral adrenal tumor: causes and clinical features in eighteen cases.

Authors:  Jiaqiang Zhou; Dan Ye; Meihua Wu; Fenping Zheng; Fang Wu; Zhou Wang; Hong Li
Journal:  Int Urol Nephrol       Date:  2008-10-11       Impact factor: 2.370

7.  Rituximab in the treatment of primary bilateral adrenal lymphoma with adrenal crisis.

Authors:  Ken-Hong Lim; Tzeun-Yuh Chiou; Cheng-Jui Lin; Ruey-Kuen Hsieh
Journal:  Med Oncol       Date:  2007-08-09       Impact factor: 3.064

8.  A case of non-Hodgkin's lymphoma primary arising in both adrenal glands associated with adrenal failure.

Authors:  Takamasa Nishiuchi; Hitomi Imachi; Mako Fujiwara; Koji Murao; Hiroaki Onishi; Tohru Kiguchi; Hidetaka Takimoto; Yoshio Kushida; Reiji Haba; Toshihiko Ishida
Journal:  Endocrine       Date:  2008-11-11       Impact factor: 3.633

9.  A case of primary adrenal diffuse large B-cell lymphoma achieving complete remission with rituximab-CHOP chemotherapy.

Authors:  Kyung Min Kim; Dok Hyun Yoon; Seung Geun Lee; Sung Nam Lim; Lyu Jin Sug; Jooryung Huh; Cheolwon Suh
Journal:  J Korean Med Sci       Date:  2009-06-16       Impact factor: 2.153

10.  Prognostic factors in primary diffuse large B-cell lymphoma of adrenal gland treated with rituximab-CHOP chemotherapy from the Consortium for Improving Survival of Lymphoma (CISL).

Authors:  Yu Ri Kim; Jin Seok Kim; Yoo Hong Min; Dok Hyunyoon; Ho-Jin Shin; Yeung-Chul Mun; Yong Park; Young Rok Do; Seong Hyun Jeong; Joon Seong Park; Sung Yong Oh; Suee Lee; Eun Kyung Park; Joung-Soon Jang; Won-Sik Lee; Hwe-Won Lee; Hyeonseok Eom; Jae-Sook Ahn; Jae-Heon Jeong; Sun Kyung Baek; Seok Jin Kim; Won Seog Kim; Cheolwon Suh
Journal:  J Hematol Oncol       Date:  2012-08-13       Impact factor: 17.388

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.